CR20150604A - Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos - Google Patents
Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidosInfo
- Publication number
- CR20150604A CR20150604A CR20150604A CR20150604A CR20150604A CR 20150604 A CR20150604 A CR 20150604A CR 20150604 A CR20150604 A CR 20150604A CR 20150604 A CR20150604 A CR 20150604A CR 20150604 A CR20150604 A CR 20150604A
- Authority
- CR
- Costa Rica
- Prior art keywords
- erythrocytes
- substances
- loaded
- preparation
- pharmaceutical interest
- Prior art date
Links
- 210000003743 erythrocyte Anatomy 0.000 title abstract 5
- 239000000126 substance Substances 0.000 title abstract 2
- 206010003594 Ataxia telangiectasia Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01001—Hexokinase (2.7.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
Abstract
La presente invención se refiere a un proceso para preparar eritrocitos cargados con una o más sustancias de interés farmacéutico. La presente invención también se dirige a eritrocitos cargados de este modo obtenidos y composiciones farmacéuticas que comprenden tal población de eritrocitos cargados así como también aplicaciones terapéuticas de los mismos, en particular en el tratamiento de Ataxia telangiectasia.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000280A ITRM20130280A1 (it) | 2013-05-10 | 2013-05-10 | Procedimento per la preparazione di eritrociti caricati con una o più sostanze di interesse farmaceutico. |
IT000610A ITRM20130610A1 (it) | 2013-11-05 | 2013-11-05 | Eritrociti caricati con una o più sostanze di interesse farmaceutico |
PCT/IB2014/061338 WO2014181309A1 (en) | 2013-05-10 | 2014-05-09 | Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20150604A true CR20150604A (es) | 2016-03-09 |
Family
ID=50981593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20150604A CR20150604A (es) | 2013-05-10 | 2015-11-05 | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos |
Country Status (19)
Country | Link |
---|---|
US (2) | US10849858B2 (es) |
EP (2) | EP4338803A2 (es) |
JP (1) | JP6367314B2 (es) |
KR (1) | KR102223080B1 (es) |
CN (1) | CN105228596B (es) |
AU (1) | AU2014264205B2 (es) |
BR (1) | BR112015028278B1 (es) |
CA (1) | CA2911976C (es) |
CR (1) | CR20150604A (es) |
ES (1) | ES2950419T3 (es) |
IL (1) | IL242503B (es) |
MX (1) | MX2015015409A (es) |
PH (1) | PH12015502535B1 (es) |
PL (1) | PL2994117T3 (es) |
PT (1) | PT2994117T (es) |
RU (1) | RU2670070C2 (es) |
SA (1) | SA515370122B1 (es) |
SG (1) | SG11201509252QA (es) |
WO (1) | WO2014181309A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2930665A1 (en) | 2013-11-18 | 2015-05-21 | Rubius Therapeutics, Inc. | Synthetic membrane-receiver complexes |
CA2944492A1 (en) | 2014-04-01 | 2015-10-08 | Rubius Therapeutics, Inc. | Methods and compositions for immunomodulation |
EP3359962B1 (en) | 2015-10-07 | 2021-11-17 | Sangui Bio Pty. Ltd | Blood preparation and profiling |
EP3393482A4 (en) * | 2015-12-22 | 2019-08-21 | Sangui Bio Pty. Ltd | THERAPEUTIC PROCEDURES USING ERYTHROCYTES |
KR101671361B1 (ko) * | 2016-08-08 | 2016-11-01 | 에스씨엠생명과학 주식회사 | TYMP(thymidine phosphorylase) 단백질을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
AU2017379367B2 (en) | 2016-12-20 | 2023-12-07 | Sangui Bio Pty. Ltd | Blood profiling with protease inhibitors |
EP3880309A1 (en) | 2018-11-15 | 2021-09-22 | Erytech Pharma | Synergistic combinations of methionine depletion agents and immune checkpoint modulators |
CN109453137A (zh) * | 2018-12-07 | 2019-03-12 | 上海交通大学 | 一种活红细胞载倍他米松磷酸钠的缓释制剂及其制备方法与应用 |
CN113008653A (zh) * | 2019-12-20 | 2021-06-22 | 深圳市帝迈生物技术有限公司 | 稀释液、血细胞分析仪、血细胞分析仪用试剂以及试剂盒 |
EP4149440A1 (en) | 2020-05-11 | 2023-03-22 | Erytech Pharma | Red cell extracellular vesicles (rcevs) containing cargoes and methods of use and production thereof |
CN111658772B (zh) * | 2020-07-22 | 2022-06-03 | 南通大学 | 一种自然光诱导控释药物及其制备方法与应用 |
CA3219808A1 (en) | 2021-05-27 | 2022-12-01 | Erydel S.P.A. | Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine |
WO2023027613A1 (ru) * | 2021-08-27 | 2023-03-02 | Общество С Ограниченной Ответственностью "Рбк-Фармэко" | Устройство и способ для включения биологически активных компонентов в эритроциты способом проточного диализа |
CN114469865B (zh) * | 2022-03-17 | 2023-09-22 | 中国医学科学院输血研究所 | 一种与血细胞膜结合的脂质体药物载体及其制备方法和用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4327710A (en) * | 1980-06-18 | 1982-05-04 | The United States Of America As Represented By The Secretary Of Agriculture | Process for encapsulating additives in resealed erythrocytes for disseminating chemicals via the circulatory system |
SU1807595A1 (ru) * | 1989-10-16 | 1996-08-10 | Целиноградский государственный медицинский институт Минздрава КазССР | Средство для лечения отравлений ртутью |
AU680890B2 (en) * | 1993-03-23 | 1997-08-14 | Cbr Laboratories, Inc. | Method and apparatus for encapsulation of biologically-active substances in cells |
DE69732225T2 (de) | 1997-05-05 | 2005-06-23 | Dideco S.R.L., Mirandola | Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür |
GB0002856D0 (en) * | 2000-02-08 | 2000-03-29 | Gendel Limited | Ultrasound sensitisation |
KR100478791B1 (ko) * | 2002-07-11 | 2005-03-24 | 오유경 | 유전자 수송체로서의 생체 적합성 혈구 세포 |
FR2873925B1 (fr) | 2004-08-05 | 2006-10-13 | Erytech Pharma Soc Par Actions | Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes |
IT1399590B1 (it) | 2010-04-26 | 2013-04-26 | Erydel Spa | Apparato e kit per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti |
ITBO20100256A1 (it) * | 2010-04-26 | 2011-10-27 | Erydel Spa | Metodo per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti |
-
2014
- 2014-05-09 EP EP23177290.6A patent/EP4338803A2/en active Pending
- 2014-05-09 CN CN201480026710.XA patent/CN105228596B/zh active Active
- 2014-05-09 WO PCT/IB2014/061338 patent/WO2014181309A1/en active Application Filing
- 2014-05-09 SG SG11201509252QA patent/SG11201509252QA/en unknown
- 2014-05-09 MX MX2015015409A patent/MX2015015409A/es active IP Right Grant
- 2014-05-09 ES ES14732387T patent/ES2950419T3/es active Active
- 2014-05-09 US US14/888,486 patent/US10849858B2/en active Active
- 2014-05-09 KR KR1020157035053A patent/KR102223080B1/ko active IP Right Grant
- 2014-05-09 JP JP2016512472A patent/JP6367314B2/ja active Active
- 2014-05-09 CA CA2911976A patent/CA2911976C/en active Active
- 2014-05-09 PL PL14732387.7T patent/PL2994117T3/pl unknown
- 2014-05-09 AU AU2014264205A patent/AU2014264205B2/en active Active
- 2014-05-09 PT PT147323877T patent/PT2994117T/pt unknown
- 2014-05-09 EP EP14732387.7A patent/EP2994117B1/en active Active
- 2014-05-09 BR BR112015028278-4A patent/BR112015028278B1/pt active IP Right Grant
- 2014-05-09 RU RU2015152801A patent/RU2670070C2/ru active
-
2015
- 2015-11-05 PH PH12015502535A patent/PH12015502535B1/en unknown
- 2015-11-05 CR CR20150604A patent/CR20150604A/es unknown
- 2015-11-08 IL IL242503A patent/IL242503B/en active IP Right Grant
- 2015-11-09 SA SA515370122A patent/SA515370122B1/ar unknown
-
2020
- 2020-10-29 US US17/083,771 patent/US20210283063A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
SA515370122B1 (ar) | 2016-11-08 |
EP2994117B1 (en) | 2023-06-07 |
PH12015502535A1 (en) | 2016-02-22 |
AU2014264205B2 (en) | 2018-08-30 |
US20210283063A1 (en) | 2021-09-16 |
RU2670070C2 (ru) | 2018-10-17 |
PL2994117T3 (pl) | 2023-10-16 |
JP6367314B2 (ja) | 2018-08-01 |
BR112015028278B1 (pt) | 2022-12-20 |
JP2016518402A (ja) | 2016-06-23 |
KR20160005781A (ko) | 2016-01-15 |
AU2014264205A1 (en) | 2015-11-12 |
MX2015015409A (es) | 2016-06-02 |
CN105228596A (zh) | 2016-01-06 |
US20160051482A1 (en) | 2016-02-25 |
KR102223080B1 (ko) | 2021-03-04 |
CN105228596B (zh) | 2018-08-24 |
US10849858B2 (en) | 2020-12-01 |
RU2015152801A (ru) | 2017-06-16 |
EP2994117A1 (en) | 2016-03-16 |
PH12015502535B1 (en) | 2016-02-22 |
PT2994117T (pt) | 2023-07-14 |
SG11201509252QA (en) | 2015-12-30 |
CA2911976C (en) | 2021-01-19 |
EP4338803A2 (en) | 2024-03-20 |
CA2911976A1 (en) | 2014-11-13 |
BR112015028278A2 (pt) | 2017-07-25 |
ES2950419T3 (es) | 2023-10-09 |
WO2014181309A1 (en) | 2014-11-13 |
IL242503B (en) | 2020-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150604A (es) | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos | |
CL2017003459A1 (es) | Derivados de sulfamoilarilamida ciclados y su uso como medicamentos para el tratamiento de la hepatitis b. | |
EA201890204A1 (ru) | Антибактериальные соединения | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
CL2016000508A1 (es) | Compuestos derivados de (2-metil-3-fenilfenil)metoxi sustituidos, inhibidores de la interacción pd-1/proteína pd-l1/proteína; composición farmacéutica que los comprende; y su uso para tratar una enfermedad infecciosa o cáncer. | |
NI201600018A (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
CL2014003444A1 (es) | Compuestos derivados tienopirimidina; proceso de preparacion; composicion farmaceutica que los comprende; combinacion farmaceutica; uso en el tratamiento de canceres y enfermedades autoinmunes. | |
CR20150376A (es) | Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos | |
NI201500161A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CU20170172A7 (es) | 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos | |
CR20150326A (es) | Inhibidores de autotaxina | |
EA201591340A1 (ru) | Модулятор андрогенного рецептора и его применения | |
EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
UY36561A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
CL2015002692A1 (es) | Novedosos compuestos de bencenosulfonamida, método para sintetizarlos y uso de los compuestos en medicina y en cosméticos. | |
CY1123490T1 (el) | Συνθεσεις που προερχονται απο χιτοζανη | |
GT201500247A (es) | Imidazopiridazinas sustituidas | |
SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
TR201910866T4 (tr) | Kanser tedavisi için birleşik preparasyonlar. | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
SV2016005293A (es) | Compuestos de azol amido-sustituidos como inhibidores de tnks1 y/o tnks2 | |
DOP2015000298A (es) | Compuestos nuevos para el tratamiento del cáncer | |
DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
DOP2016000064A (es) | Derivados de fenilalanina sustituidos | |
UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen |